Transdermal delivery system
US6667052B2 · kind B2 · utility
3Cited by
5References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 10, 2001 |
| Grant date | Dec 23, 2003 |
| Priority date | — |
| Expiry date | Aug 10, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a transdermal delivery system for treating diabetes and other pathologic systemic conditions, comprising an active ingredient selected from the group consisting of peptides and proteins having an S—S bond and mixtures thereof and a pharmaceutically acceptable oxidizing agent selected from the group consisting of iodine, povidine-iodine and sources thereof, said system being essentially free of reducing agents and said oxidizing agent enabling and facilitating the penetration of said active ingredient through the skin layers and into the blood stream.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.